There are more than 20 innovative therapies under development for treating celiac disease including a vaccine, enzyme therapies and other drugs. Celiac Disease Foundation CEO Marilyn Geller joins our Children's National team in the podcast studio to discuss how these therapies are being studied and why patient involvement in research is crucial to their development. Vanessa and Marilyn discuss the importance of patients joining clinical trials and how the Celiac Disease Foundation's iCureCeliac patient registry is helping researchers advance these important therapies.